Sec. 6093. REQUIRING THE REVIEW OF QUALITY MEASURES RELATING TO OPIOIDS AND OPIOID USE DISORDER TREATMENTS FURNISHED UNDER THE MEDICARE PROGRAM AND OTHER FEDERAL HEALTH CARE PROGRAMS
584 words·~3 min read·
/statute-compilations/comps-15290/sec-6093A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
## SEC. 6093 REQUIRING THE REVIEW OF QUALITY MEASURES RELATING TO OPIOIDS AND OPIOID USE DISORDER TREATMENTS FURNISHED UNDER THE MEDICARE PROGRAM AND OTHER FEDERAL HEALTH CARE PROGRAMS Section 1890A of the Social Security Act (42 U.S.C. 1395aaa-1) is amended by adding at the end the following new subsection: > > ### “(g) Technical Expert Panel Review of Opioid and Opioid Use Disorder Quality Measures > > > #### “(1) In general > > Not later than 180 days after the date of the enactment of this subsection, the Secretary shall establish a technical expert panel for purposes of reviewing quality measures relating to opioids and opioid use disorders, including care, prevention, diagnosis, health outcomes, and treatment furnished to individuals with opioid use disorders.
The Secretary may use the entity with a contract under section 1890(a) and amend such contract as necessary to provide for the establishment of such technical expert panel. > > > #### “(2) Review and assessment > > Not later than 1 year after the date the technical expert panel described in paragraph
(1)is established (and periodically thereafter as the Secretary determines appropriate), the technical expert panel shall— > > > ##### “(A) > > review quality measures that relate to opioids and opioid use disorders, including existing measures and those under development; > > > ##### “(B) > > identify gaps in areas of quality measurement that relate to opioids and opioid use disorders, and identify measure development priorities for such measure gaps; and > > > ##### “(C) > > make recommendations to the Secretary on quality measures with respect to opioids and opioid use disorders for purposes of improving care, prevention, diagnosis, health outcomes, and treatment, including recommendations for revisions of such measures, need for development of new measures, and recommendations for including such measures in the Merit-Based Incentive Payment System under section 1848(q), the alternative payment models under section 1833(z)(3)(C), the shared savings program under section 1899, the quality reporting requirements for inpatient hospitals under section 1886(b)(3)(B)(viii), and the hospital value-based purchasing program under section 1886(o). > > > #### “(3) Consideration of measures by secretary > > The Secretary shall consider— > > > ##### “(A) > > using opioid and opioid use disorder measures (including measures used under the Merit-Based Incentive Payment System under section 1848(q), measures recommended under paragraph (2)(C), and other such measures identified by the Secretary) in alternative payment models under section 1833(z)(3)(C) and in the shared savings program under section 1899; and > > > ##### “(B) > > using opioid measures described in subparagraph (A), as applicable, in the quality reporting requirements for inpatient hospitals under section 1886(b)(3)(B)(viii), and in the hospital value-based purchasing program under section 1886(o). > > > #### “(4) Prioritization of measure development > > The Secretary shall prioritize for measure development the gaps in quality measures identified under paragraph (2)(B). > > > #### “(5) Prioritization of measure endorsement > > The Secretary— > > > ##### “(A) > > during the period beginning on the date of the enactment of this subsection and ending on December 31, 2023, shall prioritize the endorsement of measures relating to opioids and opioid use disorders by the entity with a contract under subsection
(a)of section 1890 in connection with endorsement of measures described in subsection (b)(2) of such section; and > > > ##### “(B) > > on and after January 1, 2024, may prioritize the endorsement of such measures by such entity.” > .
Connectionstraces to 1
Traces to 1 document
Citation graph
cites case law
Sec. 6093
REQUIRING THE REVIEW OF QUALITY MEASURES RELATING TO OPIOIDS AND OPIOID USE DISORDER TREATMENTS FURNISHED UNDER THE MEDICARE PROGRAM AND OTHER FEDERAL HEALTH CARE PROGRAMS
Cites 1Cited by 0 across 0 sources